These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 28821159)
1. Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin. Alikarami F; Safa M; Faranoush M; Hayat P; Kazemi A Biomed Pharmacother; 2017 Oct; 94():1077-1093. PubMed ID: 28821159 [TBL] [Abstract][Full Text] [Related]
2. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin. Ciszewski WM; Tavecchio M; Dastych J; Curtin NJ Breast Cancer Res Treat; 2014 Jan; 143(1):47-55. PubMed ID: 24292814 [TBL] [Abstract][Full Text] [Related]
3. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase. Amrein L; Loignon M; Goulet AC; Dunn M; Jean-Claude B; Aloyz R; Panasci L J Pharmacol Exp Ther; 2007 Jun; 321(3):848-55. PubMed ID: 17351105 [TBL] [Abstract][Full Text] [Related]
4. Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination. Tavecchio M; Munck JM; Cano C; Newell DR; Curtin NJ Cancer Chemother Pharmacol; 2012 Jan; 69(1):155-64. PubMed ID: 21630086 [TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Zhao Y; Thomas HD; Batey MA; Cowell IG; Richardson CJ; Griffin RJ; Calvert AH; Newell DR; Smith GC; Curtin NJ Cancer Res; 2006 May; 66(10):5354-62. PubMed ID: 16707462 [TBL] [Abstract][Full Text] [Related]
6. Targeting the DNA double strand break repair machinery in prostate cancer. Shaheen FS; Znojek P; Fisher A; Webster M; Plummer R; Gaughan L; Smith GC; Leung HY; Curtin NJ; Robson CN PLoS One; 2011; 6(5):e20311. PubMed ID: 21629734 [TBL] [Abstract][Full Text] [Related]
7. Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity. Mould E; Berry P; Jamieson D; Hill C; Cano C; Tan N; Elliott S; Durkacz B; Newell D; Willmore E Biochem Pharmacol; 2014 Mar; 88(1):58-65. PubMed ID: 24418411 [TBL] [Abstract][Full Text] [Related]
8. HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia. Tharkar-Promod S; Johnson DP; Bennett SE; Dennis EM; Banowsky BG; Jones SS; Shearstone JR; Quayle SN; Min C; Jarpe M; Mosbruger T; Pomicter AD; Miles RR; Chen WY; Bhalla KN; Zweidler-McKay PA; Shrieve DC; Deininger MW; Chandrasekharan MB; Bhaskara S Leukemia; 2018 Jan; 32(1):49-60. PubMed ID: 28579617 [TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia. Elliott SL; Crawford C; Mulligan E; Summerfield G; Newton P; Wallis J; Mainou-Fowler T; Evans P; Bedwell C; Durkacz BW; Willmore E Br J Haematol; 2011 Jan; 152(1):61-71. PubMed ID: 21083655 [TBL] [Abstract][Full Text] [Related]
10. DNA-dependent protein kinase: effect on DSB repair, G2/M checkpoint and mode of cell death in NSCLC cell lines. Sak A; Groneberg M; Stuschke M Int J Radiat Biol; 2019 Sep; 95(9):1205-1219. PubMed ID: 31287365 [No Abstract] [Full Text] [Related]
11. DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy. Chua ML; Horn S; Somaiah N; Davies S; Gothard L; A'Hern R; Yarnold J; Rothkamm K Radiat Environ Biophys; 2014 May; 53(2):355-64. PubMed ID: 24622963 [TBL] [Abstract][Full Text] [Related]
12. Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition. Ćmielová J; Havelek R; Vávrová J; Řezáčová M Med Oncol; 2015 May; 32(5):138. PubMed ID: 25801233 [TBL] [Abstract][Full Text] [Related]
13. Nontoxic concentration of DNA-PK inhibitor NU7441 radio-sensitizes lung tumor cells with little effect on double strand break repair. Sunada S; Kanai H; Lee Y; Yasuda T; Hirakawa H; Liu C; Fujimori A; Uesaka M; Okayasu R Cancer Sci; 2016 Sep; 107(9):1250-5. PubMed ID: 27341700 [TBL] [Abstract][Full Text] [Related]
14. Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair. Gustafsson AS; Abramenkovs A; Stenerlöw B Mutat Res; 2014 Nov; 769():1-10. PubMed ID: 25771720 [TBL] [Abstract][Full Text] [Related]
15. Inactivation of DNA-PK by knockdown DNA-PKcs or NU7441 impairs non-homologous end-joining of radiation-induced double strand break repair. Dong J; Ren Y; Zhang T; Wang Z; Ling CC; Li GC; He F; Wang C; Wen B Oncol Rep; 2018 Mar; 39(3):912-920. PubMed ID: 29344644 [TBL] [Abstract][Full Text] [Related]
16. DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia. Willmore E; Elliott SL; Mainou-Fowler T; Summerfield GP; Jackson GH; O'Neill F; Lowe C; Carter A; Harris R; Pettitt AR; Cano-Soumillac C; Griffin RJ; Cowell IG; Austin CA; Durkacz BW Clin Cancer Res; 2008 Jun; 14(12):3984-92. PubMed ID: 18559621 [TBL] [Abstract][Full Text] [Related]
17. DNA-PK inhibition causes a low level of H2AX phosphorylation and homologous recombination repair in Medaka (Oryzias latipes) cells. Urushihara Y; Kobayashi J; Matsumoto Y; Komatsu K; Oda S; Mitani H Biochem Biophys Res Commun; 2012 Dec; 429(3-4):131-6. PubMed ID: 23142596 [TBL] [Abstract][Full Text] [Related]
18. Co-targeting deoxyribonucleic acid-dependent protein kinase and poly(adenosine diphosphate-ribose) polymerase-1 promotes accelerated senescence of irradiated cancer cells. Azad A; Bukczynska P; Jackson S; Haupt Y; Cullinane C; McArthur GA; Solomon B Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):385-94. PubMed ID: 24411611 [TBL] [Abstract][Full Text] [Related]
19. Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441. Tichy A; Durisova K; Salovska B; Pejchal J; Zarybnicka L; Vavrova J; Dye NA; Sinkorova Z Radiat Environ Biophys; 2014 Mar; 53(1):83-92. PubMed ID: 24100951 [TBL] [Abstract][Full Text] [Related]
20. DNA repair protein DNA-PK protects PC12 cells from oxidative stress-induced apoptosis involving AKT phosphorylation. Cardinale A; Saladini S; Lupacchini L; Ruspantini I; De Dominicis C; Papale M; Silvagno F; Garaci E; Mollinari C; Merlo D Mol Biol Rep; 2022 Feb; 49(2):1089-1101. PubMed ID: 34797489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]